Management of Radiologically Isolated Syndrome (RIS) in Adults

Diagnostic Criteria

Apply the same MRI dissemination‑in‑space (DIS) and dissemination‑in‑time (DIT) criteria used for multiple‑sclerosis diagnosis when evaluating RIS patients, as recommended by the Lancet Neurology consensus (2016) 1, 2.

Perform a complete spinal‑cord MRI at initial evaluation because the presence of spinal‑cord lesions markedly raises the 5‑year risk of conversion to clinical MS (Nature Reviews Neurology, 2015) 3.
Test for aquaporin‑4 (AQP4) antibodies to exclude neuromyelitis optica spectrum disorder before confirming RIS, given the distinct management and prognosis of NMOSD (Nature Reviews Neurology, 2015) 4, 5.

Conduct a follow‑up brain MRI 3–6 months after the index scan to identify new T2 or gadolinium‑enhancing lesions, which independently increase the likelihood of a clinical event (Nature Reviews Neurology, 2015) 3.
Schedule brain MRI every 3–6 months during the first year of observation (Nature Reviews Neurology, 2015) 3.
Reserve routine spinal‑cord MRI for specific clinical indications, as it adds limited value for regular surveillance (Nature Reviews Neurology, 2015) 3.
If the second brain MRI shows no new lesions, obtain a third scan at 6–12 months; the emergence of new T2 lesions or gadolinium enhancement represents radiological dissemination in time and substantially raises MS conversion risk (Nature Reviews Neurology, 2015) 3.

Diagnose multiple sclerosis when a RIS patient experiences a clinical attack and already meets DIT criteria, because DIS is already satisfied (Lancet Neurology, 2016) 1, 2.
Do not differentiate between symptomatic and asymptomatic MRI lesions when applying DIS and DIT criteria; both contribute equally to the diagnostic thresholds (Lancet Neurology, 2016) 1, 2.

Require expert neuroradiological review before labeling a case as RIS; interpretation must be performed by readers experienced in distinguishing MS‑compatible lesions from other CNS abnormalities (Nature Reviews Neurology, 2015) 4, 6.
Consider alternative acquired or inherited white‑matter diseases when imaging features are atypical, as recommended by consensus statements (Lancet Neurology, 2016) 1.
Recognize that incidental white‑matter lesions may stem from age‑related changes, migraine, or vascular disease rather than RIS, to avoid misdiagnosis (Nature Reviews Neurology, 2015) 4.

Regular brain MRI monitoring is essential for patients with RIS, with follow-up scans recommended 3-6 months after the initial MRI to detect new lesions, using T2-weighted, T2-FLAIR, and gadolinium-enhanced T1-weighted sequences 7, 8, 9
Diffusion-weighted imaging should be included when monitoring for potential progression to clinically definite MS 10

Presence of spinal cord lesions is associated with higher risk of conversion to clinically definite MS 11
Infratentorial lesions, particularly in the brainstem or cerebellum, are associated with higher risk of conversion to clinically definite MS 11

Brain MRI should be performed every 3-6 months in the first year after diagnosis, and annually thereafter for patients with stable findings 7
High-risk RIS patients should undergo more frequent monitoring (every 3-4 months) 7, 10

Patients with RIS should undergo cognitive assessment using validated tools such as the Symbol Digit Modalities Test (SDMT) every 6 months 12
Emphasize the importance of consistent follow-up imaging, even in asymptomatic patients, to detect subclinical disease progression 7